11/25/2025
Have you heard - Essilor Stellest is here!
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States clinically proven to help slow the progression of myopia in children 6 to 12 years old at the initiation of treatment.
With clinical studies showing a 67% average slowdown in myopia progression over two years, this milestone marks a new era in proactive eye health care — helping eye care professionals protect children’s vision for the future.
Essilor Stellest is available through participating EyeMed providers. Talk to your eye doctor to learn more!